SCHEMBL13642659

SCHEMBL13642659

C/C=C1/C(O)CC2C3CC=C4C[C@@H](C)CC[C@]4(C)C3CC[C@]12C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ G6PD P11413 3/20 0.56
▸ SHBG P04278 3/20 0.46
▸ SERPINA6 P08185 2/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ ESR1 P03372 1/20 0.46
▸ AR P10275 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ GUSB P08236 1/20 0.46
▸ PMP22 Q01453 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ GPBAR1 Q8TDU6 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CYP17A1 P05093 8/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ TBXAS1 P24557 1/20 0.44
▸ SRD5A2 P31213 1/20 0.44
▸ CYP19A1 P11511 1/20 0.43
▸ MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13642708 1.00 G6PD (0.56) G6PDSHBGSERPINA6CYP3A4ESR1
SCHEMBL12403266 0.89 G6PD (0.70) G6PDSHBGSERPINA6CYP3A4ESR1
SCHEMBL3670416 0.89 G6PD (0.70) G6PDSHBGSERPINA6CYP3A4ESR1
SCHEMBL13642783 0.89 G6PD (0.70) G6PDSHBGSERPINA6CYP3A4ESR1
SCHEMBL13420269 0.89 G6PD (0.70) G6PDSHBGSERPINA6CYP3A4ESR1
SCHEMBL12153536 0.89 G6PD (0.70) G6PDSHBGSERPINA6CYP3A4ESR1
SCHEMBL1126907 0.89 G6PD (0.70) G6PDSHBGSERPINA6CYP3A4ESR1
SCHEMBL1126576 0.89 G6PD (0.70) G6PDSHBGSERPINA6CYP3A4ESR1
SCHEMBL14193758 0.89 G6PD (0.70) G6PDSHBGSERPINA6CYP3A4ESR1
SCHEMBL14193756 0.89 G6PD (0.70) G6PDSHBGSERPINA6CYP3A4ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120283217-A1 MODULATORS OF AMYLOID-BETA PRODUCTION SATORI PHARMACEUTICALS, INC. (US) 2012-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283217-A1 MODULATORS OF AMYLOID-BETA PRODUCTION APP, BACE1, BACE2 G6PD 1270/4885SHBG 1588/4885SERPINA6 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback